FDA
approval
· 2021-10-08
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for Amnesteem (isotretinoin) submitted by Mylan Pharmaceuticals Inc., representing an approval of a labeling/indication …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)